Non-DNA-binding platinum anticancer agents: Cytotoxic activities of platinum–phosphato complexes towards human ovarian cancer cells
RN Bose, L Maurmann, RJ Mishur… - Proceedings of the …, 2008 - National Acad Sciences
DNA is believed to be the molecular target for the cytotoxic activities of platinum (Pt)
anticancer drugs. We report here a class of platinum (II)-and platinum (IV)-pyrophosphato …
anticancer drugs. We report here a class of platinum (II)-and platinum (IV)-pyrophosphato …
Non-DNA-binding platinum anticancer agents: Cytotoxic activities of platinum-phosphato complexes towards human ovarian cancer cells.
RN Bose, L Maurmann, RJ Mishur, L Yasui… - Proceedings of the …, 2008 - europepmc.org
DNA is believed to be the molecular target for the cytotoxic activities of platinum (Pt)
anticancer drugs. We report here a class of platinum (II)-and platinum (IV)-pyrophosphato …
anticancer drugs. We report here a class of platinum (II)-and platinum (IV)-pyrophosphato …
[PDF][PDF] Non-DNA-binding platinum anticancer agents: Cytotoxic activities of platinum–phosphato complexes towards human ovarian cancer cells
RN Bosea, L Maurmannb, RJ Mishurb, L Yasuib… - PNAS, 2008 - researchgate.net
DNA is believed to be the molecular target for the cytotoxic activities of platinum (Pt)
anticancer drugs. We report here a class of platinum (II)-and platinum (IV)-pyrophosphato …
anticancer drugs. We report here a class of platinum (II)-and platinum (IV)-pyrophosphato …
Non-DNA-Binding Platinum Anticancer Agents: Cytotoxic Activities of Platinum-Phosphato Complexes towards Human Ovarian Cancer Cells
RN Bose, L Maurmann, RJ Mishur, L Yasui… - Proceedings of the …, 2008 - JSTOR
DNA is believed to be the molecular target for the cytotoxic activities of platinum (Pt)
anticancer drugs. We report here a class of platinum (II)-and platinum (IV)-pyrophosphato …
anticancer drugs. We report here a class of platinum (II)-and platinum (IV)-pyrophosphato …
Non-DNA-binding platinum anticancer agents: Cytotoxic activities of platinum-phosphato complexes towards human ovarian cancer cells
RN Bose, L Maurmann, RJ Mishur… - Proceedings of the …, 2008 - ui.adsabs.harvard.edu
DNA is believed to be the molecular target for the cytotoxic activities of platinum (Pt)
anticancer drugs. We report here a class of platinum (II)-and platinum (IV)-pyrophosphato …
anticancer drugs. We report here a class of platinum (II)-and platinum (IV)-pyrophosphato …
[PDF][PDF] Non-DNA-binding platinum anticancer agents: Cytotoxic activities of platinum–phosphato complexes towards human ovarian cancer cells
RN Bosea, L Maurmannb, RJ Mishurb, L Yasuib… - PNAS, 2008 - academia.edu
DNA is believed to be the molecular target for the cytotoxic activities of platinum (Pt)
anticancer drugs. We report here a class of platinum (II)-and platinum (IV)-pyrophosphato …
anticancer drugs. We report here a class of platinum (II)-and platinum (IV)-pyrophosphato …
[HTML][HTML] Non-DNA-binding platinum anticancer agents: Cytotoxic activities of platinum–phosphato complexes towards human ovarian cancer cells
RN Bose, L Maurmann, RJ Mishur, L Yasui… - Proceedings of the …, 2008 - ncbi.nlm.nih.gov
DNA is believed to be the molecular target for the cytotoxic activities of platinum (Pt)
anticancer drugs. We report here a class of platinum (II)-and platinum (IV)-pyrophosphato …
anticancer drugs. We report here a class of platinum (II)-and platinum (IV)-pyrophosphato …
Non-DNA-binding platinum anticancer agents: Cytotoxic activities of platinum-phosphato complexes towards human ovarian cancer cells
RN Bose, L Maurmann, RJ Mishur… - Proceedings of the …, 2008 - pubmed.ncbi.nlm.nih.gov
DNA is believed to be the molecular target for the cytotoxic activities of platinum (Pt)
anticancer drugs. We report here a class of platinum (II)-and platinum (IV)-pyrophosphato …
anticancer drugs. We report here a class of platinum (II)-and platinum (IV)-pyrophosphato …
[PDF][PDF] Non-DNA-binding platinum anticancer agents: Cytotoxic activities of platinum–phosphato complexes towards human ovarian cancer cells
RN Bosea, L Maurmannb, RJ Mishurb, L Yasuib… - PNAS, 2008 - researchgate.net
DNA is believed to be the molecular target for the cytotoxic activities of platinum (Pt)
anticancer drugs. We report here a class of platinum (II)-and platinum (IV)-pyrophosphato …
anticancer drugs. We report here a class of platinum (II)-and platinum (IV)-pyrophosphato …